Drug-Coated Devices for Peripheral Arterial Disease

Recent analyses provide reassurance about using paclitaxel-coated devices in patients with peripheral arterial disease, but the FDA believes that clinical studies of these devices should continue and should collect long-term mortality data.

Automated summary

Recent analyses show that paclitaxel-coated devices are reassuring for treating patients with peripheral arterial disease, however, the FDA recommends continued clinical studies to collect long-term mortality data.